genetics & genomics, funding, disease & medicine
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
New Insights to Improve CAR T Cells’ Safety
New Insights to Improve CAR T Cells’ Safety
Vicki Brower | Jun 5, 2018
Drugs approved to treat rheumatoid arthritis block cytokines, the molecules responsible for severe side effects from the immunotherapy, and reduce symptoms in mice.
Image of the Day: That Toad Is Poison
Image of the Day: That Toad Is Poison
Sukanya Charuchandra | Jun 5, 2018
The introduction of the poisonous Duttaphrynus melanostictus into Madagascar could be fatally risky for the island’s native predators.
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
A T-Cell Tweak Combats Advanced Breast Cancer
A T-Cell Tweak Combats Advanced Breast Cancer
Ashley Yeager | Jun 5, 2018
The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Immunotherapy Drug Shows Promise for Melanoma, Lung Cancer
Sukanya Charuchandra | Jun 4, 2018
Merck’s Keytruda extended the lives of lung cancer patients by several months and appeared to stop the progression of advanced melanoma.  
Pioneering Heart Transplant Program Suspended
Pioneering Heart Transplant Program Suspended
Kerry Grens | Jun 4, 2018
The move by Baylor St. Luke’s Medical Center follows an investigative news report detailing surgical errors and poor research practices.
Study Finds No Race or Gender Bias in Grant Peer Review
Study Finds No Race or Gender Bias in Grant Peer Review
Shawna Williams | Jun 1, 2018
The paper’s authors say bias may nevertheless be present in other steps of the granting process.
Cell Transplant Trial for Spinal Injury Is Safe
Cell Transplant Trial for Spinal Injury Is Safe
Ruth Williams | Jun 1, 2018
The first human experiment with neural precursor cells implanted to treat chronic spinal cord injury suggests the procedure is safe, and hints at a small benefit.  
New Study Contradicts Previous Idea About Origins of South Americans
New Study Contradicts Previous Idea About Origins of South Americans
Sukanya Charuchandra | Jun 1, 2018
Divergent human lineages of North America intermingled before setting off to establish populations of Central and South America.